Live Breaking News & Updates on Oncology Stock Down

Stay updated with breaking news from Oncology stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Wedbush Downgrades Ikena Oncology (NASDAQ:IKNA) to Neutral

Wedbush downgraded shares of Ikena Oncology (NASDAQ:IKNA – Free Report) from an outperform rating to a neutral rating in a research report sent to investors on Wednesday morning, MarketBeat reports. The brokerage currently has $2.00 target price on the stock, down from their previous target price of $8.00. Wedbush also issued estimates for Ikena Oncology’s […] ....

United-states , Marquette-asset-management , Jacobs-levy-equity-management-inc , Acadian-asset-management , Ikena-oncology-inc , Ikena-oncology , Free-report , Oncology-stock-down , Get-free-report , Levy-equity-management , Asset-management

Decheng Capital LLC Acquires New Shares in Pyxis Oncology, Inc. (NASDAQ:PYXS)

Decheng Capital LLC Acquires New Shares in Pyxis Oncology, Inc. (NASDAQ:PYXS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , Commonwealth-equity-services , Pyxis-oncology-inc , Jefferies-financial-group , Acadian-asset-management , Royal-bank , Nasdaq , Decheng-capital , Schulhoff-co , Pyxis-oncology , Free-report

Brokerages Set Cullinan Oncology, Inc. (NASDAQ:CGEM) Price Target at $31.00

Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) has been given an average rating of “Buy” by the seven ratings firms that are covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have covered the stock in the last year […] ....

United-states , Jennifer-michaelson , Stifel-nicolaus , William-blair , Nasdaq , Parkman-healthcare-partners , Securities-exchange-commission , Cullinan-oncology-inc , Affinity-asset-advisors , Franklin-resources-inc , Cullinan-oncology , Get-free-report

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $8.50 Consensus Target Price from Brokerages

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $8.50 Consensus Target Price from Brokerages
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Canada , Leerink-partnrs , Acadian-asset-management , Commonwealth-equity-services , Schulhoff-co , Pyxis-oncology-inc , Nasdaq , Royal-bank , Jefferies-financial-group , Pyxis-oncology , Get-free-report , Marketbeat-ratings

Cardiff Oncology's (CRDF) "Buy" Rating Reiterated at HC Wainwright

Cardiff Oncology's (CRDF) "Buy" Rating Reiterated at HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Piper-sandler , Cardiff-oncology-company-profile , Callan-capital , Cardiff-oncology-inc , Nasdaq , Cardiff-oncology , Free-report , Oncology-stock-down , Get-free-report , Polo-like-kinase